Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc106_5, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 5 input genes in category / 13 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0000982 transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding 7.208E-5 4.042E-4 1.285E-3 9.371E-4 3 365
2 GO:0000978 RNA polymerase II proximal promoter sequence-specific DNA binding 8.063E-5 4.042E-4 1.285E-3 1.048E-3 3 379
3 GO:0000987 proximal promoter sequence-specific DNA binding 9.327E-5 4.042E-4 1.285E-3 1.213E-3 3 398
4 GO:0005154 epidermal growth factor receptor binding 8.812E-3 2.864E-2
9.107E-2
1.146E-1
 1 33

2: GO: Biological Process [Display Chart] 5 input genes in category / 154 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0071248 cellular response to metal ion 6.427E-4 3.959E-2
2.224E-1
9.898E-2
 2 151
2 GO:0071241 cellular response to inorganic substance 8.716E-4 3.959E-2
2.224E-1
1.342E-1
 2 176
3 GO:0036017 response to erythropoietin 1.342E-3 3.959E-2
2.224E-1
2.066E-1
 1 5
4 GO:0036018 cellular response to erythropoietin 1.342E-3 3.959E-2
2.224E-1
2.066E-1
 1 5
5 GO:0036015 response to interleukin-3 1.878E-3 3.959E-2
2.224E-1
2.892E-1
 1 7
6 GO:0036016 cellular response to interleukin-3 1.878E-3 3.959E-2
2.224E-1
2.892E-1
 1 7
7 GO:0060136 embryonic process involved in female pregnancy 2.146E-3 3.959E-2
2.224E-1
3.305E-1
 1 8
8 GO:0045741 positive regulation of epidermal growth factor-activated receptor activity 2.950E-3 3.959E-2
2.224E-1
4.543E-1
 1 11
9 GO:0003334 keratinocyte development 3.218E-3 3.959E-2
2.224E-1
4.956E-1
 1 12
10 GO:0010038 response to metal ion 3.664E-3 3.959E-2
2.224E-1
5.643E-1
 2 364
11 GO:0006878 cellular copper ion homeostasis 4.289E-3 3.959E-2
2.224E-1
6.605E-1
 1 16
12 GO:0097305 response to alcohol 4.365E-3 3.959E-2
2.224E-1
6.723E-1
 2 398
13 GO:0031065 positive regulation of histone deacetylation 4.556E-3 3.959E-2
2.224E-1
7.017E-1
 1 17
14 GO:0055070 copper ion homeostasis 4.824E-3 3.959E-2
2.224E-1
7.429E-1
 1 18
15 GO:0071294 cellular response to zinc ion 5.359E-3 3.959E-2
2.224E-1
8.252E-1
 1 20
16 GO:0072574 hepatocyte proliferation 5.626E-3 3.959E-2
2.224E-1
8.664E-1
 1 21
17 GO:0072575 epithelial cell proliferation involved in liver morphogenesis 5.626E-3 3.959E-2
2.224E-1
8.664E-1
 1 21
18 GO:0060749 mammary gland alveolus development 5.893E-3 3.959E-2
2.224E-1
9.076E-1
 1 22
19 GO:0060716 labyrinthine layer blood vessel development 5.893E-3 3.959E-2
2.224E-1
9.076E-1
 1 22
20 GO:0061377 mammary gland lobule development 5.893E-3 3.959E-2
2.224E-1
9.076E-1
 1 22
21 GO:0001829 trophectodermal cell differentiation 6.161E-3 3.959E-2
2.224E-1
9.487E-1
 1 23
22 GO:0072576 liver morphogenesis 6.161E-3 3.959E-2
2.224E-1
9.487E-1
 1 23
23 GO:0090312 positive regulation of protein deacetylation 6.161E-3 3.959E-2
2.224E-1
9.487E-1
 1 23
24 GO:0042493 response to drug 6.322E-3 3.959E-2
2.224E-1
9.735E-1
 2 481
25 GO:0046697 decidualization 6.428E-3 3.959E-2
2.224E-1
9.899E-1
 1 24
26 GO:0007176 regulation of epidermal growth factor-activated receptor activity 6.695E-3 3.965E-2
2.228E-1
1.000E0
 1 25
27 GO:0051412 response to corticosterone 7.229E-3 4.122E-2
2.316E-1
1.000E0
 1 27
28 GO:0031063 regulation of histone deacetylation 7.496E-3 4.122E-2
2.316E-1
1.000E0
 1 28
29 GO:0033687 osteoblast proliferation 7.763E-3 4.122E-2
2.316E-1
1.000E0
 1 29
30 GO:0060674 placenta blood vessel development 8.830E-3 4.361E-2
2.450E-1
1.000E0
 1 33
31 GO:0045742 positive regulation of epidermal growth factor receptor signaling pathway 9.363E-3 4.361E-2
2.450E-1
1.000E0
 1 35
32 GO:0001893 maternal placenta development 9.363E-3 4.361E-2
2.450E-1
1.000E0
 1 35
33 GO:1901186 positive regulation of ERBB signaling pathway 9.629E-3 4.361E-2
2.450E-1
1.000E0
 1 36
34 GO:0051385 response to mineralocorticoid 9.629E-3 4.361E-2
2.450E-1
1.000E0
 1 36
35 GO:0061098 positive regulation of protein tyrosine kinase activity 1.069E-2 4.562E-2
2.563E-1
1.000E0
 1 40
36 GO:0090311 regulation of protein deacetylation 1.096E-2 4.562E-2
2.563E-1
1.000E0
 1 41
37 GO:0001825 blastocyst formation 1.096E-2 4.562E-2
2.563E-1
1.000E0
 1 41
38 GO:2000273 positive regulation of signaling receptor activity 1.229E-2 4.981E-2
2.798E-1
1.000E0
 1 46
Show 33 more annotations

3: GO: Cellular Component [Display Chart] 5 input genes in category / 12 annotations before applied cutoff / 19061 genes in category

No results to display

4: Human Phenotype [Display Chart] 1 input genes in category / 12 annotations before applied cutoff / 4707 genes in category

No results to display

5: Mouse Phenotype [Display Chart] 4 input genes in category / 281 annotations before applied cutoff / 10355 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0008396 abnormal osteoclast differentiation 2.698E-6 7.581E-4 4.713E-3 7.581E-4 3 92
2 MP:0004982 abnormal osteoclast morphology 2.362E-5 3.319E-3 2.063E-2 6.638E-3 3 189
3 MP:0001209 spontaneous skin ulceration 7.832E-5 6.621E-3 4.117E-2 2.201E-2 2 38
4 MP:0000130 abnormal trabecular bone morphology 9.425E-5 6.621E-3 4.117E-2 2.649E-2 3 300
5 MP:0001200 thick skin 1.475E-4 7.797E-3 4.848E-2 4.144E-2 2 52
6 MP:0005501 abnormal skin physiology 1.665E-4 7.797E-3 4.848E-2 4.678E-2 3 363
7 MP:0004945 abnormal bone resorption 3.769E-4 1.064E-2
6.614E-2
1.059E-1
 2 83
8 MP:0002446 abnormal macrophage morphology 3.800E-4 1.064E-2
6.614E-2
1.068E-1
 3 479
9 MP:0013396 eyelid hyperplasia 3.863E-4 1.064E-2
6.614E-2
1.085E-1
 1 1
10 MP:0030175 orbicularis oculi muscle hypoplasia 3.863E-4 1.064E-2
6.614E-2
1.085E-1
 1 1
11 MP:0010119 abnormal bone mineral density 4.164E-4 1.064E-2
6.614E-2
1.170E-1
 3 494
12 MP:0001194 dermatitis 5.580E-4 1.307E-2
8.124E-2
1.568E-1
 2 101
13 MP:0013389 Meibomian gland hypoplasia 7.725E-4 1.356E-2
8.433E-2
2.171E-1
 1 2
14 MP:0004983 abnormal osteoclast cell number 9.805E-4 1.356E-2
8.433E-2
2.755E-1
 2 134
15 MP:0001212 skin lesions 1.040E-3 1.356E-2
8.433E-2
2.921E-1
 2 138
16 MP:0010867 abnormal bone trabecula morphology 1.070E-3 1.356E-2
8.433E-2
3.006E-1
 2 140
17 MP:0030173 abnormal orbicularis oculi muscle morphology 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
18 MP:0030172 abnormal eyelid muscle morphology 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
19 MP:0003095 abnormal corneal stroma development 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
20 MP:0004285 absent Descemet membrane 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
21 MP:0010709 absent eye anterior chamber 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
22 MP:0030426 facial muscle hypoplasia 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
23 MP:0013388 small Meibomian gland 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
24 MP:0009272 decreased guard hair length 1.159E-3 1.356E-2
8.433E-2
3.255E-1
 1 3
25 MP:0004947 skin inflammation 1.276E-3 1.435E-2
8.919E-2
3.586E-1
 2 153
26 MP:0004986 abnormal osteoblast morphology 1.395E-3 1.508E-2
9.373E-2
3.920E-1
 2 160
27 MP:0011567 increased renal glomerulus lobularity 1.544E-3 1.542E-2
9.589E-2
4.340E-1
 1 4
28 MP:0009270 abnormal guard hair length 1.544E-3 1.542E-2
9.589E-2
4.340E-1
 1 4
29 MP:0010874 abnormal bone volume 1.592E-3 1.542E-2
9.589E-2
4.472E-1
 2 171
30 MP:0001316 corneal scarring 1.930E-3 1.750E-2
1.088E-1
5.424E-1
 1 5
31 MP:0009460 skeletal muscle hypoplasia 1.930E-3 1.750E-2
1.088E-1
5.424E-1
 1 5
32 MP:0002998 abnormal bone remodeling 2.065E-3 1.813E-2
1.127E-1
5.802E-1
 2 195
33 MP:0001278 kinked vibrissae 2.316E-3 1.859E-2
1.156E-1
6.508E-1
 1 6
34 MP:0002580 duodenal lesions 2.316E-3 1.859E-2
1.156E-1
6.508E-1
 1 6
35 MP:0006194 keratoconjunctivitis 2.316E-3 1.859E-2
1.156E-1
6.508E-1
 1 6
36 MP:0010971 abnormal periosteum morphology 2.702E-3 2.109E-2
1.311E-1
7.592E-1
 1 7
37 MP:0009742 increased corneal stroma thickness 3.087E-3 2.283E-2
1.419E-1
8.675E-1
 1 8
38 MP:0004284 abnormal Descemet membrane 3.087E-3 2.283E-2
1.419E-1
8.675E-1
 1 8
39 MP:0001279 wavy vibrissae 3.473E-3 2.502E-2
1.556E-1
9.758E-1
 1 9
40 MP:0000396 increased curvature of hairs 3.858E-3 2.651E-2
1.648E-1
1.000E0
 1 10
41 MP:0001191 abnormal skin condition 3.869E-3 2.651E-2
1.648E-1
1.000E0
 2 268
42 MP:0011159 abnormal epidermal-dermal junction morphology 4.243E-3 2.839E-2
1.765E-1
1.000E0
 1 11
43 MP:0020202 abnormal macrophage cell number 4.487E-3 2.932E-2
1.823E-1
1.000E0
 2 289
44 MP:0011922 abnormal circulating osteocalcin level 4.628E-3 2.956E-2
1.838E-1
1.000E0
 1 12
45 MP:0008841 ruptured lens capsule 5.783E-3 3.532E-2
2.196E-1
1.000E0
 1 15
46 MP:0001193 psoriasis 5.783E-3 3.532E-2
2.196E-1
1.000E0
 1 15
47 MP:0003812 abnormal hair medulla 6.167E-3 3.537E-2
2.199E-1
1.000E0
 1 16
48 MP:0004796 increased anti-histone antibody level 6.167E-3 3.537E-2
2.199E-1
1.000E0
 1 16
49 MP:0013716 hypolactation 6.167E-3 3.537E-2
2.199E-1
1.000E0
 1 16
50 MP:0004686 decreased length of long bones 7.092E-3 3.986E-2
2.478E-1
1.000E0
 2 365
Show 45 more annotations

6: Domain [Display Chart] 5 input genes in category / 31 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 PF00170 bZIP 1 Pfam 5.447E-8 1.398E-6 5.629E-6 1.689E-6 3 34
2 SM00338 BRLZ SMART 2.009E-7 1.398E-6 5.629E-6 6.227E-6 3 52
3 PS00036 BZIP BASIC PROSITE 2.129E-7 1.398E-6 5.629E-6 6.601E-6 3 53
4 PS50217 BZIP PROSITE 2.129E-7 1.398E-6 5.629E-6 6.601E-6 3 53
5 IPR004827 bZIP InterPro 2.254E-7 1.398E-6 5.629E-6 6.988E-6 3 54
6 IPR000837 AP-1 InterPro 2.050E-6 1.059E-5 4.265E-5 6.355E-5 2 9
7 IPR008917 TF DNA-bd InterPro 3.781E-5 1.674E-4 6.743E-4 1.172E-3 2 37
8 IPR029819 JDP2 InterPro 2.669E-4 8.273E-4 3.332E-3 8.273E-3 1 1
9 IPR029814 Fra2 InterPro 2.669E-4 8.273E-4 3.332E-3 8.273E-3 1 1
10 IPR029822 JunB InterPro 2.669E-4 8.273E-4 3.332E-3 8.273E-3 1 1
11 IPR005643 JNK InterPro 8.005E-4 1.909E-3 7.687E-3 2.481E-2 1 3
12 PF03957 Jun Pfam 8.005E-4 1.909E-3 7.687E-3 2.481E-2 1 3
13 IPR002112 Leuzip Jun InterPro 8.005E-4 1.909E-3 7.687E-3 2.481E-2 1 3
14 IPR015497 EGF rcpt ligand InterPro 1.867E-3 4.134E-3 1.665E-2
5.788E-2
 1 7
15 IPR018064 Metalthion vert metal BS InterPro 2.666E-3 5.258E-3 2.117E-2
8.265E-2
 1 10
16 IPR017854 Metalthion dom InterPro 3.199E-3 5.258E-3 2.117E-2
9.916E-2
 1 12
17 4.10.10.10 - Gene3D 3.199E-3 5.258E-3 2.117E-2
9.916E-2
 1 12
18 IPR023587 Metalthion dom vert InterPro 3.199E-3 5.258E-3 2.117E-2
9.916E-2
 1 12
19 PS00203 METALLOTHIONEIN VRT PROSITE 3.465E-3 5.258E-3 2.117E-2
1.074E-1
 1 13
20 PF00131 Metallothio Pfam 3.731E-3 5.258E-3 2.117E-2
1.157E-1
 1 14
21 IPR000006 Metalthion vert InterPro 3.731E-3 5.258E-3 2.117E-2
1.157E-1
 1 14
22 IPR003019 Metalthion InterPro 3.731E-3 5.258E-3 2.117E-2
1.157E-1
 1 14
23 1.10.880.10 - Gene3D 4.263E-3 5.746E-3 2.314E-2
1.322E-1
 1 16
24 PF07716 bZIP 2 Pfam 4.529E-3 5.850E-3 2.356E-2
1.404E-1
 1 17
25 PF00008 EGF Pfam 3.318E-2 4.114E-2
1.657E-1
1.000E0
 1 126
Show 20 more annotations

7: Pathway [Display Chart] 5 input genes in category / 42 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 138006 ATF-2 transcription factor network BioSystems: Pathway Interaction Database 1.900E-4 7.980E-3 3.453E-2 7.980E-3 2 55
2 193147 Osteoclast differentiation BioSystems: KEGG 1.060E-3 2.226E-2
9.631E-2
 4.452E-2 2 130
3 1339158 Metallothioneins bind metals BioSystems: REACTOME 4.411E-3 3.365E-2
1.456E-1
1.852E-1
 1 11
4 1339157 Response to metal ions BioSystems: REACTOME 4.411E-3 3.365E-2
1.456E-1
1.852E-1
 1 11
5 138016 ErbB receptor signaling network BioSystems: Pathway Interaction Database 5.211E-3 3.365E-2
1.456E-1
2.189E-1
 1 13
6 M2602 Bone Remodelling MSigDB C2 BIOCARTA (v6.0) 5.611E-3 3.365E-2
1.456E-1
2.357E-1
 1 14
7 M1394 GATA3 participate in activating the Th2 cytokine genes expression MSigDB C2 BIOCARTA (v6.0) 6.410E-3 3.365E-2
1.456E-1
2.692E-1
 1 16
8 1427841 TFAP2 (AP-2) family regulates transcription of growth factors and their receptors BioSystems: REACTOME 6.410E-3 3.365E-2
1.456E-1
2.692E-1
 1 16
9 137941 Calcium signaling in the CD4+ TCR pathway BioSystems: Pathway Interaction Database 1.120E-2 4.491E-2
1.943E-1
4.702E-1
 1 28
10 169349 Validated transcriptional targets of AP1 family members Fra1 and Fra2 BioSystems: Pathway Interaction Database 1.358E-2 4.491E-2
1.943E-1
5.705E-1
 1 34
11 1309087 Cargo concentration in the ER BioSystems: REACTOME 1.358E-2 4.491E-2
1.943E-1
5.705E-1
 1 34
12 1269528 SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription BioSystems: REACTOME 1.358E-2 4.491E-2
1.943E-1
5.705E-1
 1 34
13 137935 FOXM1 transcription factor network BioSystems: Pathway Interaction Database 1.477E-2 4.491E-2
1.943E-1
6.205E-1
 1 37
14 1427839 Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors BioSystems: REACTOME 1.596E-2 4.491E-2
1.943E-1
6.705E-1
 1 40
15 137932 IL6-mediated signaling events BioSystems: Pathway Interaction Database 1.715E-2 4.491E-2
1.943E-1
7.204E-1
 1 43
16 1269527 Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer BioSystems: REACTOME 1.834E-2 4.491E-2
1.943E-1
7.703E-1
 1 46
17 137993 Calcineurin-regulated NFAT-dependent transcription in lymphocytes BioSystems: Pathway Interaction Database 1.913E-2 4.491E-2
1.943E-1
8.035E-1
 1 48
18 138018 Downstream signaling in naive CD8+ T cells BioSystems: Pathway Interaction Database 1.992E-2 4.491E-2
1.943E-1
8.368E-1
 1 50
19 212237 Mineral absorption BioSystems: KEGG 2.032E-2 4.491E-2
1.943E-1
8.534E-1
 1 51
20 83119 Non-small cell lung cancer BioSystems: KEGG 2.308E-2 4.718E-2
2.041E-1
9.694E-1
 1 58
21 83108 Pancreatic cancer BioSystems: KEGG 2.544E-2 4.718E-2
2.041E-1
1.000E0
 1 64
22 83110 Glioma BioSystems: KEGG 2.544E-2 4.718E-2
2.041E-1
1.000E0
 1 64
23 83107 Renal cell carcinoma BioSystems: KEGG 2.584E-2 4.718E-2
2.041E-1
1.000E0
 1 65
24 1268727 COPII (Coat Protein 2) Mediated Vesicle Transport BioSystems: REACTOME 2.780E-2 4.865E-2
2.105E-1
1.000E0
 1 70
Show 19 more annotations

8: Pubmed [Display Chart] 5 input genes in category / 899 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1633872 Expression of c-fos, c-jun, jun-B, metallothionein and metalloproteinase genes in human chondrocyte. Pubmed 1.371E-8 6.163E-6 4.548E-5 1.233E-5 2 2
2 14499865 Hypertrophic agonists induce the binding of c-Fos to an AP-1 site in cardiac myocytes: implications for the expression of GLUT1. Pubmed 1.371E-8 6.163E-6 4.548E-5 1.233E-5 2 2
3 9154808 Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Pubmed 8.226E-8 1.849E-5 1.364E-4 7.395E-5 2 4
4 15558021 MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability. Pubmed 8.226E-8 1.849E-5 1.364E-4 7.395E-5 2 4
5 11948401 AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Pubmed 1.371E-7 2.465E-5 1.819E-4 1.232E-4 2 5
6 19321746 Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Pubmed 2.056E-7 3.081E-5 2.273E-4 1.849E-4 2 6
7 18679426 The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice. Pubmed 2.879E-7 3.697E-5 2.728E-4 2.588E-4 2 7
8 21937452 Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription. Pubmed 3.838E-7 4.313E-5 3.182E-4 3.450E-4 2 8
9 19289495 Trophoblast stem cell maintenance by fibroblast growth factor 4 requires MEKK4 activation of Jun N-terminal kinase. Pubmed 4.934E-7 4.436E-5 3.273E-4 4.436E-4 2 9
10 24411941 Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers. Pubmed 4.934E-7 4.436E-5 3.273E-4 4.436E-4 2 9
11 9858769 Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Pubmed 2.096E-6 1.713E-4 1.264E-3 1.884E-3 2 18
12 20930145 Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators. Pubmed 3.164E-6 2.370E-4 1.749E-3 2.844E-3 2 22
13 23475960 c-Jun is required for the specification of joint cell fates. Pubmed 5.559E-6 3.844E-4 2.837E-3 4.997E-3 2 29
14 28089446 STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1. Pubmed 6.366E-6 4.017E-4 2.964E-3 5.723E-3 2 31
15 20102225 Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays. Pubmed 6.790E-6 4.017E-4 2.964E-3 6.104E-3 2 32
16 24952347 DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NFκB complex in the (de-)methylation of TRAF1. Pubmed 3.689E-5 4.017E-4 2.964E-3 3.317E-2 2 74
17 7765502 Different gene expression of mouse transforming growth factor alpha between pregnant mammary glands and mammary tumors in C3H/He mice. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
18 15829639 Postpubertal sex differentiation of forebrain structures and functions depend on transforming growth factor-alpha. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
19 3459638 The gene for human transforming growth factor alpha is on the short arm of chromosome 2. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
20 22513431 Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
21 15041247 Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
22 19097988 Nickel mobilizes intracellular zinc to induce metallothionein in human airway epithelial cells. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
23 8299590 Characterization of the synthesis and secretion of transforming growth factor-alpha from salivary glands and saliva. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
24 20039427 The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
25 17306025 The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
26 24157868 Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
27 19780938 Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
28 10918574 Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
29 21225234 Expression of junB is markedly stimulated by glycyrrhizin in a human hepatoma cell line. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
30 7947554 Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
31 23742131 Microarray analysis of two single-nucleotide polymorphisms of transforming growth factor alpha in patients with nonsyndromic cleft of north china. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
32 16439969 Delayed wound healing and epidermal hyperproliferation in mice lacking JunB in the skin. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
33 11597899 Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
34 24952512 Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
35 10523832 Human keratinocytes and tumor-derived cell lines express alternatively spliced forms of transforming growth factor-alpha mRNA, encoding precursors lacking carboxyl-terminal valine residues. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
36 23553990 MiR-23a in amplified 19p13.13 loci targets metallothionein 2A and promotes growth in gastric cancer cells. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
37 23155381 Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
38 26594907 Polymorphism of Metallothionein 2A Modifies Lead Body Burden in Workers Chronically Exposed to the Metal. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
39 24464219 Fra-2/AP-1 controls adipocyte differentiation and survival by regulating PPARγ and hypoxia. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
40 2161707 Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
41 16365389 Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
42 22824183 Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
43 23308222 JunB mediates basal- and TGFβ1-induced smooth muscle cell contractility. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
44 7727772 Transforming growth factor-alpha (TGF-alpha) in human bone marrow: demonstration of TGF-alpha in erythroblasts and eosinophilic precursor cells and of epidermal growth factor receptors in blastlike cells of myelomonocytic origin. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
45 16340132 Inhibition of NFAT increases osteoblast differentiation by increasing Fra-2 expression. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
46 19933934 Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
47 12468378 Paracrine action of transforming growth factor-alpha in rectal crypt epithelium of humans. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
48 26754630 JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
49 3855503 Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
50 24027048 Loss of stromal JUNB does not affect tumor growth and angiogenesis. Pubmed 1.309E-4 4.017E-4 2.964E-3
1.177E-1
 1 1
Show 45 more annotations

9: Interaction [Display Chart] 5 input genes in category / 164 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:ATF7 ATF7 interactions 1.149E-7 1.885E-5 1.071E-4 1.885E-5 3 41
2 int:JUND JUND interactions 3.150E-7 2.583E-5 1.467E-4 5.167E-5 3 57
3 int:JUNB JUNB interactions 6.688E-7 3.656E-5 2.077E-4 1.097E-4 3 73
4 int:ATF2 ATF2 interactions 2.042E-5 7.327E-4 4.162E-3 3.348E-3 3 227
5 int:TRIB1 TRIB1 interactions 2.234E-5 7.327E-4 4.162E-3 3.663E-3 2 27
6 int:DET1 DET1 interactions 2.958E-5 7.756E-4 4.405E-3 4.851E-3 2 31
7 int:IRF2BP1 IRF2BP1 interactions 3.567E-5 7.756E-4 4.405E-3 5.851E-3 2 34
8 int:JDP2 JDP2 interactions 3.783E-5 7.756E-4 4.405E-3 6.204E-3 2 35
9 int:JUN JUN interactions 4.514E-5 8.225E-4 4.672E-3 7.403E-3 3 296
10 int:ATF1 ATF1 interactions 5.736E-5 9.408E-4 5.344E-3 9.408E-3 2 43
11 int:STK40 STK40 interactions 7.466E-5 1.113E-3 6.322E-3 1.224E-2 2 49
12 int:CREB5 CREB5 interactions 9.079E-5 1.232E-3 7.000E-3 1.489E-2 2 54
13 int:EGR1 EGR1 interactions 9.769E-5 1.232E-3 7.000E-3 1.602E-2 2 56
14 int:FOSL2 FOSL2 interactions 1.122E-4 1.315E-3 7.467E-3 1.840E-2 2 60
15 int:DDIT3 DDIT3 interactions 1.949E-4 2.131E-3 1.211E-2 3.197E-2 2 79
16 int:DNMT3L DNMT3L interactions 2.311E-4 2.368E-3 1.345E-2 3.789E-2 2 86
17 int:COP1 COP1 interactions 2.820E-4 2.720E-3 1.545E-2 4.624E-2 2 95
18 int:MAPK9 MAPK9 interactions 5.114E-4 4.623E-3 2.626E-2
8.387E-2
 2 128
19 int:GOPC GOPC interactions 5.356E-4 4.623E-3 2.626E-2
8.783E-2
 2 131
20 int:CXorf40A CXorf40A interactions 8.471E-4 6.946E-3 3.946E-2
1.389E-1
 1 3
21 int:NKX2-1 NKX2-1 interactions 9.637E-4 7.526E-3 4.275E-2
1.580E-1
 2 176
22 int:ZNF595 ZNF595 interactions 1.129E-3 8.419E-3 4.782E-2
1.852E-1
 1 4
23 int:MAPK8 MAPK8 interactions 1.407E-3 1.003E-2
5.698E-2
2.307E-1
 2 213
24 int:HOXA7 HOXA7 interactions 1.694E-3 1.068E-2
6.068E-2
2.778E-1
 1 6
25 int:MEIS3 MEIS3 interactions 1.694E-3 1.068E-2
6.068E-2
2.778E-1
 1 6
26 int:ZSWIM9 ZSWIM9 interactions 1.694E-3 1.068E-2
6.068E-2
2.778E-1
 1 6
27 int:RHBDF1 RHBDF1 interactions 2.258E-3 1.336E-2
7.589E-2
3.703E-1
 1 8
28 int:MAPK14 MAPK14 interactions 2.281E-3 1.336E-2
7.589E-2
3.741E-1
 2 272
29 int:PKIA PKIA interactions 2.822E-3 1.596E-2
9.063E-2
4.627E-1
 1 10
30 int:PBX4 PBX4 interactions 3.385E-3 1.850E-2
1.051E-1
5.551E-1
 1 12
31 int:BAHCC1 BAHCC1 interactions 3.948E-3 2.080E-2
1.182E-1
6.475E-1
 1 14
32 int:FOSB FOSB interactions 4.230E-3 2.080E-2
1.182E-1
6.937E-1
 1 15
33 int:NEU1 NEU1 interactions 4.511E-3 2.080E-2
1.182E-1
7.399E-1
 1 16
34 int:SPINK7 SPINK7 interactions 4.793E-3 2.080E-2
1.182E-1
7.860E-1
 1 17
35 int:CREBBP CREBBP interactions 4.820E-3 2.080E-2
1.182E-1
7.905E-1
 2 398
36 int:BACH2 BACH2 interactions 5.074E-3 2.080E-2
1.182E-1
8.322E-1
 1 18
37 int:BATF2 BATF2 interactions 5.074E-3 2.080E-2
1.182E-1
8.322E-1
 1 18
38 int:TGFA TGFA interactions 5.074E-3 2.080E-2
1.182E-1
8.322E-1
 1 18
39 int:ALX3 ALX3 interactions 5.074E-3 2.080E-2
1.182E-1
8.322E-1
 1 18
40 int:DBP DBP interactions 5.074E-3 2.080E-2
1.182E-1
8.322E-1
 1 18
41 int:MAGI2 MAGI2 interactions 5.637E-3 2.125E-2
1.207E-1
9.244E-1
 1 20
42 int:TEDC1 TEDC1 interactions 5.637E-3 2.125E-2
1.207E-1
9.244E-1
 1 20
43 int:BDNF BDNF interactions 5.637E-3 2.125E-2
1.207E-1
9.244E-1
 1 20
44 int:BATF BATF interactions 5.918E-3 2.125E-2
1.207E-1
9.705E-1
 1 21
45 int:MT2A MT2A interactions 6.199E-3 2.125E-2
1.207E-1
1.000E0
 1 22
46 int:CYTH3 CYTH3 interactions 6.199E-3 2.125E-2
1.207E-1
1.000E0
 1 22
47 int:DHODH DHODH interactions 6.480E-3 2.125E-2
1.207E-1
1.000E0
 1 23
48 int:SPAST SPAST interactions 6.480E-3 2.125E-2
1.207E-1
1.000E0
 1 23
49 int:IRF2BPL IRF2BPL interactions 6.480E-3 2.125E-2
1.207E-1
1.000E0
 1 23
50 int:TSR3 TSR3 interactions 6.480E-3 2.125E-2
1.207E-1
1.000E0
 1 23
Show 45 more annotations

10: Cytoband [Display Chart] 5 input genes in category / 5 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 2p13 2p13 3.458E-3 1.332E-2 3.040E-2 1.729E-2 1 24
2 16q13 16q13 5.326E-3 1.332E-2 3.040E-2 2.663E-2 1 37
3 2p23.3 2p23.3 9.915E-3 1.652E-2 3.773E-2 4.957E-2 1 69
4 14q24.3 14q24.3 1.363E-2 1.704E-2 3.890E-2
6.815E-2
 1 95
5 19p13.2 19p13.2 3.345E-2 3.345E-2
7.637E-2
1.672E-1
 1 235

11: Transcription Factor Binding Site [Display Chart] 4 input genes in category / 74 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 4 input genes in category / 4 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 506 Basic leucine zipper proteins genenames.org 7.329E-8 2.932E-7 6.108E-7 2.932E-7 3 49
2 1257 Basic leucine zipper proteins|Jun transcription factor family genenames.org 6.594E-4 1.172E-3 2.442E-3 2.638E-3 1 3
3 1256 Basic leucine zipper proteins|Fos transcription factor family genenames.org 8.792E-4 1.172E-3 2.442E-3 3.517E-3 1 4
4 638 Metallothioneins genenames.org 4.171E-3 4.171E-3 8.690E-3 1.668E-2 1 19

13: Coexpression [Display Chart] 5 input genes in category / 1216 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M19622 Genes up-regulated in HK-2 cells kidney tubular epithelium) under hypoxia and down-regulated on re-oxygenation. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.834E-8 9.526E-5 7.317E-4 9.526E-5 3 47
2 M1379 Genes down-regulated in the intestine after the tissue specific knockout of PTEN [GeneID=5728] by Cre-lox. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.843E-7 4.768E-4 3.663E-3 9.537E-4 2 7
3 M1663 Genes up-regulated in rFSH-17 cells (primary granulosa) after stimulation with FSH. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.344E-6 5.449E-4 4.185E-3 1.635E-3 2 9
4 19190338-SuppTable1 Human StemCell Chau09 160genes GeneSigDB 2.013E-6 6.121E-4 4.701E-3 2.448E-3 3 137
5 M2502 Genes whose expression changes in Calu-6 cells (lung cancer) by TNF [GeneID=7124] were blocked partially by p38 inhibitor LY479754. MSigDB C2: CGP Curated Gene Sets (v6.0) 3.213E-6 6.465E-4 4.965E-3 3.907E-3 3 160
6 M8792 Genes up-regulated in T reg (FOXP3+ [GeneID=50943]) cells from B6 mice: Foxp3-Fusion-GFP versus Foxp3-ires-GFP. MSigDB C7: Immunologic Signatures (v6.0) 4.733E-6 6.465E-4 4.965E-3 5.755E-3 3 182
7 M8802 Genes down-regulated in Foxp3-Fusion-GFP T reg (FOXP3+ [GeneID=50943]): B6 versus NOD background. MSigDB C7: Immunologic Signatures (v6.0) 5.052E-6 6.465E-4 4.965E-3 6.143E-3 3 186
8 14990357-Table2 Rat Lung not cancer Wagenaar04 20genes GeneSigDB 5.075E-6 6.465E-4 4.965E-3 6.171E-3 2 17
9 M10550 Delayed early genes (DEG) which are coordinately down-regulated in multiple epithelial tumor types. MSigDB C2: CGP Curated Gene Sets (v6.0) 5.709E-6 6.465E-4 4.965E-3 6.942E-3 2 18
10 M8654 Genes down-regulated in P14 CD8+ T cells: ST2 [GeneID=6761] knockout versus wildtype. MSigDB C7: Immunologic Signatures (v6.0) 6.282E-6 6.465E-4 4.965E-3 7.639E-3 3 200
11 M10027 Genes down-regulated in NK cells versus ITGAM+ [GeneID=3684] dendritic cells. MSigDB C7: Immunologic Signatures (v6.0) 6.282E-6 6.465E-4 4.965E-3 7.639E-3 3 200
12 M1633 Genes up-regulated in 3T3-L1 cells (adipocyte) by insulin [GeneID=3630] but displayed blunted response to insulin the insulin resistant cells. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.380E-6 6.465E-4 4.965E-3 7.758E-3 2 19
13 15077194-table1 Human StemCell Scian04 29genes GeneSigDB 7.833E-6 6.804E-4 5.226E-3 9.525E-3 2 21
14 15173083-Table2 Human Brain Levy04 32genes GeneSigDB 7.833E-6 6.804E-4 5.226E-3 9.525E-3 2 21
15 17638852-Table4 Human Lymphoma Shin07 38genes GeneSigDB 2.090E-5 1.694E-3 1.302E-2 2.542E-2 2 34
16 M1502 Up-regulated in murine dorsal skin cells at 6 h after treatment with the phorbol ester carcinogen TPA [PubChem=4792]. MSigDB C2: CGP Curated Gene Sets (v6.0) 3.206E-5 2.436E-3 1.871E-2 3.898E-2 2 42
17 17699800-Table1 Human Lung Joo07 54genes GeneSigDB 5.323E-5 3.608E-3 2.771E-2
6.472E-2
 2 54
18 M12676 Class NT (non-tolerizeable) genes: induced during the first LPS stimulation and induced at equal or greater degree in tolerant macrophages. MSigDB C2: CGP Curated Gene Sets (v6.0) 5.341E-5 3.608E-3 2.771E-2
6.494E-2
 3 409
19 M1218 Genes up-regulated in hepatocellular carcinoma (HCC) developed by transgenic mice overexpressing a secretable form of EGF [GeneID=1950] in liver. MSigDB C2: CGP Curated Gene Sets (v6.0) 5.935E-5 3.737E-3 2.870E-2
7.217E-2
 2 57
20 14990357-Table3 Rat Lung not cancer Wagenaar04 78genes GeneSigDB 6.146E-5 3.737E-3 2.870E-2
7.474E-2
 2 58
21 11906190-Table1a-2 Human Colon Iizaka02 83genes GeneSigDB 8.970E-5 5.194E-3 3.990E-2
1.091E-1
 2 70
22 15720813-TableS2a Human Brain Hoelzinger05 100genes GeneSigDB 1.115E-4 6.161E-3 4.732E-2
1.355E-1
 2 78
23 M1435 Genes up-regulated in macrophages by aerolysin-related cytotoxic enterotoxin (Act) from Aeromonas hydrophila. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.324E-4 7.001E-3
5.378E-2
1.610E-1
 2 85
24 M1167 Selected genes up-regulated during progression through benign to malignant skin tumors formed by treatment with DMBA and TPA [PubChem=6001;4792] chemicals in the two stage skin carcinogenesis model. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.420E-4 7.063E-3
5.425E-2
1.726E-1
 2 88
25 12771951-Table1 Human Skin Dazard03 92genes GeneSigDB 1.452E-4 7.063E-3
5.425E-2
1.766E-1
 2 89
26 17488685-SuppTable1 Human Leukemia Chiaretti07 108genes GeneSigDB 1.871E-4 8.749E-3
6.720E-2
2.275E-1
 2 101
27 M12300 Up-regulated genesin the left ventricle myocardium of patients with heart failure following implantation of LVAD (left ventricular assist device). MSigDB C2: CGP Curated Gene Sets (v6.0) 1.946E-4 8.762E-3
6.730E-2
2.366E-1
 2 103
28 15735721-Table3 Human Lung Dauer05 137genes GeneSigDB 2.100E-4 8.969E-3
6.889E-2
2.553E-1
 2 107
29 M15148 Genes down-regulated in P14 nerves of transgenic mice having hypomorhic (reduced function) allele of EGR2 [GeneID=1959]. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.139E-4 8.969E-3
6.889E-2
2.601E-1
 2 108
30 M2568 Genes up-regulated in lung tissue upon LPS aspiration with mechanical ventilation (MV) compared to control (PBS aspiration without MV). MSigDB C2: CGP Curated Gene Sets (v6.0) 3.004E-4 9.986E-3
7.670E-2
3.653E-1
 2 128
31 11988840-Table1 Human Breast Oh02 170genes GeneSigDB 3.292E-4 9.986E-3
7.670E-2
4.003E-1
 2 134
32 M8796 Genes up-regulated in splenocytes from Foxp3-Fusion-GFP NOD mice: T reg (FOXP3+ [GeneID=50943]) versus T conv (FOXP3- [GeneID=50943]) cells. MSigDB C7: Immunologic Signatures (v6.0) 3.695E-4 9.986E-3
7.670E-2
4.493E-1
 2 142
33 M8789 Genes up-regulated in peritoneal macrophages: poly(IC) versus Pam3Cys-Ser-(Lys)4 [PubChem=130704]. MSigDB C7: Immunologic Signatures (v6.0) 3.906E-4 9.986E-3
7.670E-2
4.749E-1
 2 146
34 M15066 Genes up-regulated in MCF-7 cells (breast cancer) by overexpression of CMYB [GeneID=4602] off adenovirus vector. MSigDB C2: CGP Curated Gene Sets (v6.0) 4.984E-4 9.986E-3
7.670E-2
6.061E-1
 2 165
35 M9445 Genes down-regulated in splenocytes: control versus infected with Baki-1 MuLV virus. MSigDB C7: Immunologic Signatures (v6.0) 5.105E-4 9.986E-3
7.670E-2
6.208E-1
 2 167
36 18974375-TableS2 Human Lymphoma Chng09 209genes GeneSigDB 5.166E-4 9.986E-3
7.670E-2
6.282E-1
 2 168
37 M2822 Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL2 [Gene ID=3558]. MSigDB C6: Oncogenic Signatures (v6.0) 6.669E-4 9.986E-3
7.670E-2
8.110E-1
 2 191
38 15735721-SuppTable1a Human Lung Dauer05 200genes GeneSigDB 6.879E-4 9.986E-3
7.670E-2
8.365E-1
 2 194
39 M4926 Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee before vaccination versus that after the vaccination. MSigDB C7: Immunologic Signatures (v6.0) 7.021E-4 9.986E-3
7.670E-2
8.537E-1
 2 196
40 M4164 Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h. MSigDB C7: Immunologic Signatures (v6.0) 7.092E-4 9.986E-3
7.670E-2
8.624E-1
 2 197
41 M8151 Genes up-regulated in HEK293 cells over-expressing wildtype NOD2 [GeneID=64127]: untreated versus muramyl dipeptide [PubChem=11620162] for 2h. MSigDB C7: Immunologic Signatures (v6.0) 7.092E-4 9.986E-3
7.670E-2
8.624E-1
 2 197
42 M10828 Human orthologs of genes up-regulated in the crb ('crash and burn') zebrafish mutant that represents a loss-of-function mutation in BMYB [GeneID=4605]. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.092E-4 9.986E-3
7.670E-2
8.624E-1
 2 197
43 M7664 Genes down-regulated in the in vitro follicular dendritic cells from peripheral lymph nodes: non-stimulated versus tretinoin [PubChem=444795] (96h). MSigDB C7: Immunologic Signatures (v6.0) 7.164E-4 9.986E-3
7.670E-2
8.712E-1
 2 198
44 M4930 Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination. MSigDB C7: Immunologic Signatures (v6.0) 7.164E-4 9.986E-3
7.670E-2
8.712E-1
 2 198
45 M7560 Genes down-regulated in CD11b+ cells from BALB/c mice bearing 4T1 mammary carcinoma: spleen of BALB/c mice: spleen versus tumor infiltrating monocytes. MSigDB C7: Immunologic Signatures (v6.0) 7.164E-4 9.986E-3
7.670E-2
8.712E-1
 2 198
46 M4192 Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h. MSigDB C7: Immunologic Signatures (v6.0) 7.164E-4 9.986E-3
7.670E-2
8.712E-1
 2 198
47 M8326 Genes up-regulated in BCL6 [GeneID=604] high follicular helper T cells versus naïve T CD4 [GeneID=920] cells. MSigDB C7: Immunologic Signatures (v6.0) 7.236E-4 9.986E-3
7.670E-2
8.799E-1
 2 199
48 M8735 Genes down-regulated in T cells: control versus IL2 [GeneID=3558] stimulation for 17h. MSigDB C7: Immunologic Signatures (v6.0) 7.236E-4 9.986E-3
7.670E-2
8.799E-1
 2 199
49 M8105 Genes up-regulated in IL10 [GeneID=3586] knockout macrophages: unstimulated versus LPS. MSigDB C7: Immunologic Signatures (v6.0) 7.236E-4 9.986E-3
7.670E-2
8.799E-1
 2 199
50 M4169 Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 24 h. MSigDB C7: Immunologic Signatures (v6.0) 7.236E-4 9.986E-3
7.670E-2
8.799E-1
 2 199
Show 45 more annotations

14: Coexpression Atlas [Display Chart] 5 input genes in category / 939 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GSM854269 500 Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2 Immgen.org, GSE15907 5.696E-7 5.349E-4 3.970E-3 5.349E-4 4 404
2 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Ureter Junk/Ureter Normal RCC Junk/Ureter Normal RCC IN18 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Ureter Junk/Ureter Normal RCC Junk/Ureter Normal RCC IN18 Adult, Development, and Cancer types 6.413E-6 3.011E-3 2.235E-2 6.021E-3 2 18
3 10X Human 8K PBMC CD8 T cell Subtype CD8 T cell-GZMK CCL5 NKG7 Top 200 Genes 10X Human 8K PBMC CD8 T cell Subtype CD8 T cell-GZMK CCL5 NKG7 Top 200 Genes 4.198E-5 8.493E-3
6.304E-2
 3.942E-2 3 356
4 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Th cell/Kidney Tumour RCC Th cell Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Th cell/Kidney Tumour RCC Th cell Adult, Development, and Cancer types 4.519E-5 8.493E-3
6.304E-2
 4.243E-2 2 47
5 JC hmvEC 2500 K3 JC hmvEC top-relative-expression-ranked 2500 k-means-cluster#3 PCBC 4.523E-5 8.493E-3
6.304E-2
 4.247E-2 3 365
6 GSM605823 500 Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 Immgen.org, GSE15907 6.349E-5 9.088E-3
6.746E-2
5.962E-2
 3 409
7 GSM854338 500 Myeloid Cells, GN.Arth.SynF, CD11b+ Ly6-G+, Synovial Fluid, avg-3 Immgen.org, GSE15907 6.775E-5 9.088E-3
6.746E-2
6.362E-2
 3 418
8 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP2-like Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP2-like Adult, Development, and Cancer types 8.680E-5 1.019E-2
7.563E-2
8.151E-2
 2 65
9 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup8/Fos BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup8/Fos BrainMap 1.384E-4 1.272E-2
9.441E-2
1.299E-1
 2 82
10 PCBC ratio EB BM CD34+ vs EB blastocyst cfr-2X-p05 EB BM CD34+ vs EB blastocyst-Confounder removed-fold2.0 adjp0.05 PCBC_AltAnalyze 1.418E-4 1.272E-2
9.441E-2
1.331E-1
 2 83
11 JC hmvEC 1000 K1 JC hmvEC top-relative-expression-ranked 1000 k-means-cluster#1 PCBC 2.358E-4 1.272E-2
9.441E-2
2.214E-1
 2 107
12 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Proliferating NK cell Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Proliferating NK cell Adult, Development, and Cancer types 3.014E-4 1.272E-2
9.441E-2
2.830E-1
 2 121
13 Sample Type by Project: Shred 1/TCGA-Testes/Testicular Germ Cell Tumor/Testicular Germ Cell Tumor/6/3 Sample Type by Project: Shred 1/TCGA-Testes/Testicular Germ Cell Tumor/Testicular Germ Cell Tumor/6/3 TCGA-Testes 4.325E-4 1.272E-2
9.441E-2
4.061E-1
 2 145
14 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney IF-U/Kidney Normal VHL RCC IF-U/Kidney Normal VHL RCC IF18 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney IF-U/Kidney Normal VHL RCC IF-U/Kidney Normal VHL RCC IF18 Adult, Development, and Cancer types 4.581E-4 1.272E-2
9.441E-2
4.301E-1
 1 2
15 6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s1 intermediate neurons Subtype intermediate neurons s1 Top 100 Genes 6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s1 intermediate neurons Subtype intermediate neurons s1 Top 100 Genes 5.068E-4 1.272E-2
9.441E-2
4.758E-1
 2 157
16 Sample Type by Project: Shred 1/TCGA-Uterus/Uterine Carcinoma/Uterine Carcinosarcoma Heterologous Type/3/3 Sample Type by Project: Shred 1/TCGA-Uterus/Uterine Carcinoma/Uterine Carcinosarcoma Heterologous Type/3/3 TCGA-Uterus 5.068E-4 1.272E-2
9.441E-2
4.758E-1
 2 157
17 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Fos BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Fos BrainMap 5.461E-4 1.272E-2
9.441E-2
5.127E-1
 2 163
18 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Cbr2 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Cbr2 BrainMap 5.937E-4 1.272E-2
9.441E-2
5.575E-1
 2 170
19 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/excitatory/subGroup4/Calb1 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/excitatory/subGroup4/Calb1 BrainMap 5.937E-4 1.272E-2
9.441E-2
5.575E-1
 2 170
20 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal VHL RCC Nephron epithelium/Kidney Normal VHL RCC N14 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal VHL RCC Nephron epithelium/Kidney Normal VHL RCC N14 Adult, Development, and Cancer types 6.652E-4 1.272E-2
9.441E-2
6.247E-1
 2 180
21 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Endothelium/Kidney Normal-Medulla post-natal kidney Endothelium/Kidney Normal-Medulla post-natal kidney T11 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Endothelium/Kidney Normal-Medulla post-natal kidney Endothelium/Kidney Normal-Medulla post-natal kidney T11 Adult, Development, and Cancer types 6.652E-4 1.272E-2
9.441E-2
6.247E-1
 2 180
22 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP1-like/Kidney Tumour Wilms MNP1-like Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP1-like/Kidney Tumour Wilms MNP1-like Adult, Development, and Cancer types 6.652E-4 1.272E-2
9.441E-2
6.247E-1
 2 180
23 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup7/Adora2a BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup7/Adora2a BrainMap 6.726E-4 1.272E-2
9.441E-2
6.316E-1
 2 181
24 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Fetus other/Kidney Normal Wilms Fetus other/Kidney Normal Wilms F13 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Fetus other/Kidney Normal Wilms Fetus other/Kidney Normal Wilms F13 Adult, Development, and Cancer types 6.800E-4 1.272E-2
9.441E-2
6.385E-1
 2 182
25 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal-Medulla Wilms Nephron epithelium/Kidney Normal-Medulla Wilms N8 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal-Medulla Wilms Nephron epithelium/Kidney Normal-Medulla Wilms N8 Adult, Development, and Cancer types 6.800E-4 1.272E-2
9.441E-2
6.385E-1
 2 182
26 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Junk/Kidney Normal fetal kidney Junk/Kidney Normal fetal kidney IN3 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Junk/Kidney Normal fetal kidney Junk/Kidney Normal fetal kidney IN3 Adult, Development, and Cancer types 6.875E-4 1.272E-2
9.441E-2
6.455E-1
 2 183
27 6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s14 intermediate neurons Subtype intermediate neurons s14 Top 100 Genes 6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s14 intermediate neurons Subtype intermediate neurons s14 Top 100 Genes 6.875E-4 1.272E-2
9.441E-2
6.455E-1
 2 183
28 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney PT-U/Kidney Normal-Medulla post-natal kidney PT-U/Kidney Normal-Medulla post-natal kidney PT17 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney PT-U/Kidney Normal-Medulla post-natal kidney PT-U/Kidney Normal-Medulla post-natal kidney PT17 Adult, Development, and Cancer types 6.875E-4 1.272E-2
9.441E-2
6.455E-1
 2 183
29 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Tumour RCC Nephrogenesis/Kidney Tumour RCC F7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Tumour RCC Nephrogenesis/Kidney Tumour RCC F7 Adult, Development, and Cancer types 6.950E-4 1.272E-2
9.441E-2
6.526E-1
 2 184
30 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Tumour RCC R U/Kidney Tumour RCC R7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Tumour RCC R U/Kidney Tumour RCC R7 Adult, Development, and Cancer types 7.025E-4 1.272E-2
9.441E-2
6.596E-1
 2 185
31 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney PT-U/Kidney Tumour RCC PT-U/Kidney Tumour RCC PT7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney PT-U/Kidney Tumour RCC PT-U/Kidney Tumour RCC PT7 Adult, Development, and Cancer types 7.025E-4 1.272E-2
9.441E-2
6.596E-1
 2 185
32 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Tumour Wilms R U/Kidney Tumour Wilms R21 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Tumour Wilms R U/Kidney Tumour Wilms R21 Adult, Development, and Cancer types 7.025E-4 1.272E-2
9.441E-2
6.596E-1
 2 185
33 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Normal-Medulla post-natal kidney Nephrogenesis/Kidney Normal-Medulla post-natal kidney F7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Normal-Medulla post-natal kidney Nephrogenesis/Kidney Normal-Medulla post-natal kidney F7 Adult, Development, and Cancer types 7.025E-4 1.272E-2
9.441E-2
6.596E-1
 2 185
34 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney U U/Kidney Tumour RCC U U/Kidney Tumour RCC U7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney U U/Kidney Tumour RCC U U/Kidney Tumour RCC U7 Adult, Development, and Cancer types 7.025E-4 1.272E-2
9.441E-2
6.596E-1
 2 185
35 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal-Medulla post-natal kidney Nephron epithelium/Kidney Normal-Medulla post-natal kidney N11 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephron epithelium/Kidney Normal-Medulla post-natal kidney Nephron epithelium/Kidney Normal-Medulla post-natal kidney N11 Adult, Development, and Cancer types 7.025E-4 1.272E-2
9.441E-2
6.596E-1
 2 185
36 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Tumour Wilms NK cell/Kidney Tumour Wilms NK3 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Tumour Wilms NK cell/Kidney Tumour Wilms NK3 Adult, Development, and Cancer types 7.025E-4 1.272E-2
9.441E-2
6.596E-1
 2 185
37 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney IF-U/Kidney Tumour RCC IF-U/Kidney Tumour RCC IF7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney IF-U/Kidney Tumour RCC IF-U/Kidney Tumour RCC IF7 Adult, Development, and Cancer types 7.101E-4 1.272E-2
9.441E-2
6.668E-1
 2 186
38 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Renal cell carcinoma/Kidney Tumour RCC Renal cell carcinoma/Kidney Tumour RCC T7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Renal cell carcinoma/Kidney Tumour RCC Renal cell carcinoma/Kidney Tumour RCC T7 Adult, Development, and Cancer types 7.177E-4 1.272E-2
9.441E-2
6.739E-1
 2 187
39 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Normal VHL RCC R U/Kidney Normal VHL RCC R18 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Normal VHL RCC R U/Kidney Normal VHL RCC R18 Adult, Development, and Cancer types 7.177E-4 1.272E-2
9.441E-2
6.739E-1
 2 187
40 GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC hEndo Overall Top 200 Genes GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC hEndo Overall Top 200 Genes GSE76381_EmbryoMoleculeCountsPMLog2 7.253E-4 1.272E-2
9.441E-2
6.811E-1
 2 188
41 GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC hEndo Top 200 GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC hEndo Top 200 GSE76381_EmbryoMoleculeCountsPMLog2 7.253E-4 1.272E-2
9.441E-2
6.811E-1
 2 188
42 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Endothelium/Kidney Tumour RCC Endothelium/Kidney Tumour RCC N7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Endothelium/Kidney Tumour RCC Endothelium/Kidney Tumour RCC N7 Adult, Development, and Cancer types 7.253E-4 1.272E-2
9.441E-2
6.811E-1
 2 188
43 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP2/Kidney NephrogenicRest Wilms MNP2 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney MNP2/Kidney NephrogenicRest Wilms MNP2 Adult, Development, and Cancer types 7.253E-4 1.272E-2
9.441E-2
6.811E-1
 2 188
44 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag Tabula Muris Consortium 7.330E-4 1.272E-2
9.441E-2
6.883E-1
 2 189
45 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Normal-Cortex post-natal kidney Nephrogenesis/Kidney Normal-Cortex post-natal kidney F11 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney Normal-Cortex post-natal kidney Nephrogenesis/Kidney Normal-Cortex post-natal kidney F11 Adult, Development, and Cancer types 7.407E-4 1.272E-2
9.441E-2
6.956E-1
 2 190
46 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Renal cell carcinoma/Kidney Normal-Cortex Wilms Renal cell carcinoma/Kidney Normal-Cortex Wilms T9 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Renal cell carcinoma/Kidney Normal-Cortex Wilms Renal cell carcinoma/Kidney Normal-Cortex Wilms T9 Adult, Development, and Cancer types 7.407E-4 1.272E-2
9.441E-2
6.956E-1
 2 190
47 Human Cell Atlas Human Cell Atlas T cell T cell Overall Top 200 Genes Human Cell Atlas Human Cell Atlas T cell T cell Overall Top 200 Genes 7.407E-4 1.272E-2
9.441E-2
6.956E-1
 2 190
48 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney NephrogenicRest Wilms Nephrogenesis/Kidney NephrogenicRest Wilms F10 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Nephrogenesis/Kidney NephrogenicRest Wilms Nephrogenesis/Kidney NephrogenicRest Wilms F10 Adult, Development, and Cancer types 7.485E-4 1.272E-2
9.441E-2
7.029E-1
 2 191
49 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Normal-Medulla post-natal kidney NK cell/Kidney Normal-Medulla post-natal kidney NK11 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Normal-Medulla post-natal kidney NK cell/Kidney Normal-Medulla post-natal kidney NK11 Adult, Development, and Cancer types 7.485E-4 1.272E-2
9.441E-2
7.029E-1
 2 191
50 GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC hPeric Top 200 GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC hPeric Top 200 GSE76381_EmbryoMoleculeCountsPMLog2 7.563E-4 1.272E-2
9.441E-2
7.102E-1
 2 192
Show 45 more annotations

15: Computational [Display Chart] 4 input genes in category / 53 annotations before applied cutoff / 10037 genes in category

No results to display

16: MicroRNA [Display Chart] 5 input genes in category / 246 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-496.1:TargetScan hsa-miR-496.1 TargetScan 2.291E-5 5.635E-3 3.429E-2 5.635E-3 2 110
2 hsa-miR-508-5p:PITA hsa-miR-508-5p:PITA TOP PITA 7.284E-5 8.939E-3
5.439E-2
 1.792E-2 2 196
3 GTACTGT,MIR-101:MSigDB GTACTGT,MIR-101:MSigDB MSigDB 1.110E-4 8.939E-3
5.439E-2
 2.731E-2 2 242
4 hsa-miR-30e-5p:Functional MTI Functional MTI miRTarbase 2.279E-4 8.939E-3
5.439E-2
5.606E-2
 2 347
5 hsa-miR-30d-5p:Functional MTI Functional MTI miRTarbase 2.562E-4 8.939E-3
5.439E-2
6.302E-2
 2 368
6 hsa-miR-3186-5p:mirSVR lowEffct hsa-miR-3186-5p:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 3.040E-4 8.939E-3
5.439E-2
7.478E-2
 2 401
7 hsa-miR-670-3p:TargetScan hsa-miR-670-3p TargetScan 3.055E-4 8.939E-3
5.439E-2
7.515E-2
 2 402
8 hsa-miR-133a-3p.1:TargetScan hsa-miR-133a-3p.1 TargetScan 3.239E-4 8.939E-3
5.439E-2
7.968E-2
 2 414
9 hsa-miR-30b-5p:Functional MTI Functional MTI miRTarbase 3.270E-4 8.939E-3
5.439E-2
8.045E-2
 2 416
10 hsa-miR-101:PITA hsa-miR-101:PITA TOP PITA 4.330E-4 9.173E-3
5.581E-2
1.065E-1
 2 479
11 hsa-miR-133a-3p.2:TargetScan hsa-miR-133a-3p.2 TargetScan 4.475E-4 9.173E-3
5.581E-2
1.101E-1
 2 487
12 hsa-miR-133b:TargetScan hsa-miR-133b TargetScan 4.475E-4 9.173E-3
5.581E-2
1.101E-1
 2 487
13 hsa-miR-553:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.920E-4 1.309E-2
7.967E-2
1.702E-1
 1 10
14 hsa-miR-3193:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.303E-4 1.459E-2
8.877E-2
2.043E-1
 1 12
15 hsa-miR-1539:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.176E-3 1.929E-2
1.174E-1
2.893E-1
 1 17
16 hsa-miR-6743-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.522E-3 2.340E-2
1.424E-1
3.744E-1
 1 22
17 hsa-miR-4734:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.660E-3 2.402E-2
1.462E-1
4.084E-1
 1 24
18 hsa-miR-744-5p:TargetScan hsa-miR-744-5p TargetScan 2.144E-3 2.465E-2
1.500E-1
5.274E-1
 1 31
19 hsa-miR-574-3p:PITA hsa-miR-574-3p:PITA TOP PITA 2.213E-3 2.465E-2
1.500E-1
5.444E-1
 1 32
20 hsa-miR-4521:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.282E-3 2.465E-2
1.500E-1
5.614E-1
 1 33
21 hsa-miR-744:PITA hsa-miR-744:PITA TOP PITA 2.420E-3 2.465E-2
1.500E-1
5.954E-1
 1 35
22 hsa-miR-4281:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.420E-3 2.465E-2
1.500E-1
5.954E-1
 1 35
23 hsa-miR-6816-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.420E-3 2.465E-2
1.500E-1
5.954E-1
 1 35
24 hsa-miR-4515:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.766E-3 2.465E-2
1.500E-1
6.803E-1
 1 40
25 hsa-miR-663:PITA hsa-miR-663:PITA TOP PITA 3.249E-3 2.465E-2
1.500E-1
7.992E-1
 1 47
26 hsa-miR-3613-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.249E-3 2.465E-2
1.500E-1
7.992E-1
 1 47
27 hsa-miR-8075:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.456E-3 2.465E-2
1.500E-1
8.502E-1
 1 50
28 hsa-miR-3169:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.456E-3 2.465E-2
1.500E-1
8.502E-1
 1 50
29 hsa-miR-4641:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.594E-3 2.465E-2
1.500E-1
8.841E-1
 1 52
30 hsa-miR-6755-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.663E-3 2.465E-2
1.500E-1
9.011E-1
 1 53
31 hsa-miR-8072:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.732E-3 2.465E-2
1.500E-1
9.181E-1
 1 54
32 hsa-miR-3960:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.732E-3 2.465E-2
1.500E-1
9.181E-1
 1 54
33 hsa-miR-3136-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.870E-3 2.465E-2
1.500E-1
9.520E-1
 1 56
34 hsa-miR-7155-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.870E-3 2.465E-2
1.500E-1
9.520E-1
 1 56
35 hsa-miR-4743-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.077E-3 2.465E-2
1.500E-1
1.000E0
 1 59
36 hsa-miR-1273g-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.284E-3 2.465E-2
1.500E-1
1.000E0
 1 62
37 hsa-miR-6757-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.491E-3 2.465E-2
1.500E-1
1.000E0
 1 65
38 hsa-miR-4679:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.767E-3 2.465E-2
1.500E-1
1.000E0
 1 69
39 hsa-miR-520f-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.767E-3 2.465E-2
1.500E-1
1.000E0
 1 69
40 hsa-miR-566:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.767E-3 2.465E-2
1.500E-1
1.000E0
 1 69
41 hsa-miR-7151-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.836E-3 2.465E-2
1.500E-1
1.000E0
 1 70
42 hsa-miR-4727-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.974E-3 2.465E-2
1.500E-1
1.000E0
 1 72
43 hsa-miR-203a-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.111E-3 2.465E-2
1.500E-1
1.000E0
 1 74
44 hsa-miR-3178:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.180E-3 2.465E-2
1.500E-1
1.000E0
 1 75
45 hsa-miR-4761-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.318E-3 2.465E-2
1.500E-1
1.000E0
 1 77
46 hsa-miR-4749-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.732E-3 2.465E-2
1.500E-1
1.000E0
 1 83
47 hsa-miR-5087:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.732E-3 2.465E-2
1.500E-1
1.000E0
 1 83
48 hsa-miR-222-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.732E-3 2.465E-2
1.500E-1
1.000E0
 1 83
49 hsa-miR-376c-3p:Functional MTI Functional MTI miRTarbase 5.801E-3 2.465E-2
1.500E-1
1.000E0
 1 84
50 hsa-miR-133b:Functional MTI Functional MTI miRTarbase 5.801E-3 2.465E-2
1.500E-1
1.000E0
 1 84
Show 45 more annotations

17: Drug [Display Chart] 5 input genes in category / 2892 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1937 UP Azacyclonol [115-46-8]; Up 200; 15uM; PC3; HG-U133A Broad Institute CMAP Up 1.854E-8 5.361E-5 4.582E-4 5.361E-5 4 180
2 CID000068764 IBI-C83 Stitch 1.379E-6 1.357E-3 1.160E-2 3.989E-3 2 9
3 2651 UP Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT HG-U133A Broad Institute CMAP Up 3.154E-6 1.357E-3 1.160E-2 9.121E-3 3 157
4 2886 UP Prenylamine lactate [69-43-2]; Up 200; 9.6uM; MCF7; HT HG-U133A Broad Institute CMAP Up 3.402E-6 1.357E-3 1.160E-2 9.839E-3 3 161
5 486 UP calmidazolium chloride; Up 200; 5uM; MCF7; HG-U133A Broad Institute CMAP Up 3.663E-6 1.357E-3 1.160E-2 1.059E-2 3 165
6 ctd:D024502 alpha-Tocopherol CTD 3.867E-6 1.357E-3 1.160E-2 1.118E-2 3 168
7 4680 UP Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 4.007E-6 1.357E-3 1.160E-2 1.159E-2 3 170
8 2957 UP Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; HL60; HT HG-U133A Broad Institute CMAP Up 4.078E-6 1.357E-3 1.160E-2 1.179E-2 3 171
9 3464 UP Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT HG-U133A Broad Institute CMAP Up 4.223E-6 1.357E-3 1.160E-2 1.221E-2 3 173
10 958 UP resveratrol; Up 200; 10uM; MCF7; HT HG-U133A EA Broad Institute CMAP Up 4.758E-6 1.376E-3 1.176E-2 1.376E-2 3 180
11 ctd:D007608 Kainic Acid CTD 6.051E-6 1.591E-3 1.360E-2 1.750E-2 3 195
12 ctd:C424127 SL 327 CTD 1.148E-5 2.766E-3 2.364E-2 3.319E-2 2 25
13 ctd:C479072 delta-tocopherol CTD 1.243E-5 2.766E-3 2.364E-2 3.596E-2 2 26
14 ctd:C005266 quinomethionate CTD 1.343E-5 2.774E-3 2.371E-2 3.883E-2 2 27
15 ctd:C020735 dibutyldichlorotin CTD 1.664E-5 3.207E-3 2.741E-2 4.811E-2 2 30
16 CID004633087 AC1NDX9W Stitch 2.274E-5 4.097E-3 3.501E-2
6.578E-2
 2 35
17 ctd:D024504 gamma-Tocopherol CTD 2.408E-5 4.097E-3 3.501E-2
6.964E-2
 2 36
18 CID000008515 SP600125 Stitch 3.856E-5 6.195E-3
5.295E-2
1.115E-1
 3 362
19 CID003025353 L024104 Stitch 4.307E-5 6.556E-3
5.603E-2
1.246E-1
 2 48
20 ctd:C065250 4-hydroxy-equilenin CTD 5.259E-5 7.521E-3
6.428E-2
1.521E-1
 2 53
21 CID000336564 NSC-351324 Stitch 5.461E-5 7.521E-3
6.428E-2
1.579E-1
 2 54
22 CID000040024 deoxynivalenol Stitch 7.447E-5 9.522E-3
8.138E-2
2.154E-1
 2 63
23 CID000001287 AC1L1B55 Stitch 7.573E-5 9.522E-3
8.138E-2
2.190E-1
 3 454
24 ctd:D000728 Androgens CTD 7.930E-5 9.556E-3
8.168E-2
2.293E-1
 2 65
25 CID000002374 tBuBHQ Stitch 8.941E-5 9.901E-3
8.462E-2
2.586E-1
 2 69
26 ctd:D016566 Organoselenium Compounds CTD 9.469E-5 9.901E-3
8.462E-2
2.739E-1
 2 71
27 ctd:C418118 CI 1044 CTD 1.144E-4 9.901E-3
8.462E-2
3.307E-1
 2 78
28 ctd:C031278 2-chloroethyl ethyl sulfide CTD 1.424E-4 9.901E-3
8.462E-2
4.117E-1
 2 87
29 CID000289984 acetylbetulinic acid Stitch 1.457E-4 9.901E-3
8.462E-2
4.212E-1
 2 88
30 ctd:D016291 Dizocilpine Maleate CTD 1.490E-4 9.901E-3
8.462E-2
4.309E-1
 2 89
31 ctd:D006851 Hydrochloric Acid CTD 1.662E-4 9.901E-3
8.462E-2
4.807E-1
 2 94
32 CID000444218 AC1L9FY1 Stitch 1.919E-4 9.901E-3
8.462E-2
5.551E-1
 2 101
33 CID005289333 1,3,2-dioxaborolan-2-ol Stitch 2.035E-4 9.901E-3
8.462E-2
5.885E-1
 2 104
34 CID003048118 D 233 Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
35 CID000492997 AZT-Ac Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
36 CID000497923 AZT-ClOH Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
37 CID000455949 thiokojibiose octaacetate Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
38 CID000454317 AC1L9RJZ Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
39 CID000455951 thioisomaltose Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
40 CID000464372 CGP 61755 Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
41 CID000341189 NSC372809 Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
42 CID000023407 3,4-dimethylbenzyl alcohol Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
43 CID000492995 AZT-iLeu Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
44 CID005386612 trans-bis(resorcylaldoximato)copper(II Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
45 CID000072432 thionigerose Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
46 CID000020011 NSC172971 Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
47 CID000497924 AZT-Phen Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
48 CID000454922 U-89674 Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
49 CID000492994 AZT-Leu Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
50 CID003012918 calolongic acid Stitch 2.189E-4 9.901E-3
8.462E-2
6.331E-1
 1 1
Show 45 more annotations

18: Disease [Display Chart] 5 input genes in category / 286 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C0267797 Acute hepatitis DisGeNET Curated 2.665E-5 5.701E-3 3.555E-2 7.622E-3 2 27
2 C0338106 Adenocarcinoma of colon DisGeNET BeFree 3.987E-5 5.701E-3 3.555E-2 1.140E-2 3 260
3 C0042373 Vascular Diseases DisGeNET Curated 1.123E-4 8.034E-3
5.009E-2
 3.211E-2 3 368
4 C0553694 Oropharyngeal disorders DisGeNET BeFree 1.124E-4 8.034E-3
5.009E-2
 3.214E-2 2 55
5 C1562312 Estrogen receptor positive tumor DisGeNET BeFree 3.085E-4 1.496E-2
9.327E-2
8.824E-2
 1 1
6 C0022680 Polycystic Kidney Diseases DisGeNET Curated 3.651E-4 1.496E-2
9.327E-2
1.044E-1
 2 99
7 C0334299 Carcinoid tumor no ICD-O subtype DisGeNET BeFree 3.875E-4 1.496E-2
9.327E-2
1.108E-1
 2 102
8 C1519689 Tumor Promotion DisGeNET BeFree 4.184E-4 1.496E-2
9.327E-2
1.197E-1
 2 106
9 C0349218 Recurrent depressive disorder, unspecified DisGeNET Curated 6.170E-4 1.604E-2
1.000E-1
1.765E-1
 1 2
10 C0399474 Dysplastic oral leukoplakia DisGeNET BeFree 6.170E-4 1.604E-2
1.000E-1
1.765E-1
 1 2
11 C0334268 Schneiderian papilloma DisGeNET BeFree 6.170E-4 1.604E-2
1.000E-1
1.765E-1
 1 2
12 C0085413 Polycystic Kidney, Autosomal Dominant DisGeNET Curated 7.812E-4 1.862E-2
1.161E-1
2.234E-1
 2 145
13 C4085370 Fibromatosis, Palmar DisGeNET BeFree 9.254E-4 2.036E-2
1.269E-1
2.647E-1
 1 3
14 C0595989 Carcinoma of larynx DisGeNET Curated 1.084E-3 2.215E-2
1.381E-1
3.101E-1
 2 171
15 C2720436 Fibrosis of pleura DisGeNET BeFree 1.234E-3 2.321E-2
1.447E-1
3.528E-1
 1 4
16 C0007095 Carcinoid Tumor DisGeNET Curated 1.392E-3 2.321E-2
1.447E-1
3.982E-1
 2 194
17 C0017155 Gastritis, Hypertrophic DisGeNET BeFree 1.542E-3 2.321E-2
1.447E-1
4.410E-1
 1 5
18 C0271527 Cryptogenic sexual precocity DisGeNET BeFree 1.542E-3 2.321E-2
1.447E-1
4.410E-1
 1 5
19 C3658266 Prostatic Cancer, Castration-Resistant DisGeNET BeFree 1.542E-3 2.321E-2
1.447E-1
4.410E-1
 1 5
20 C0034067 Pulmonary Emphysema DisGeNET Curated 1.834E-3 2.520E-2
1.571E-1
5.246E-1
 2 223
21 C0746556 metabolic disturbance DisGeNET BeFree 1.850E-3 2.520E-2
1.571E-1
5.291E-1
 1 6
22 C0238462 Medullary carcinoma of thyroid DisGeNET Curated 2.052E-3 2.644E-2
1.648E-1
5.868E-1
 2 236
23 C1321547 T-cell/histiocyte rich large B-cell lymphoma DisGeNET BeFree 2.158E-3 2.644E-2
1.648E-1
6.173E-1
 1 7
24 C0019159 Hepatitis A DisGeNET BeFree 2.465E-3 2.644E-2
1.648E-1
7.050E-1
 2 259
25 C0333355 Inflammatory disease of mucous membrane DisGeNET Curated 2.466E-3 2.644E-2
1.648E-1
7.053E-1
 1 8
26 C0162869 Aneurysm, Ruptured DisGeNET BeFree 2.774E-3 2.644E-2
1.648E-1
7.934E-1
 1 9
27 C0264545 Thickening of pleura DisGeNET BeFree 2.774E-3 2.644E-2
1.648E-1
7.934E-1
 1 9
28 C0022354 Jaundice, Obstructive DisGeNET Curated 2.774E-3 2.644E-2
1.648E-1
7.934E-1
 1 9
29 C0002893 Refractory anemias DisGeNET Curated 3.059E-3 2.644E-2
1.648E-1
8.748E-1
 2 289
30 C1260325 Dendritic Cell Sarcoma, Follicular DisGeNET BeFree 3.082E-3 2.644E-2
1.648E-1
8.815E-1
 1 10
31 C4045991 Perihilar Cholangiocarcinoma DisGeNET BeFree 3.082E-3 2.644E-2
1.648E-1
8.815E-1
 1 10
32 C0019158 Hepatitis DisGeNET Curated 3.228E-3 2.644E-2
1.648E-1
9.231E-1
 2 297
33 C1861537 OROFACIAL CLEFT 1 DisGeNET Curated 3.390E-3 2.644E-2
1.648E-1
9.695E-1
 1 11
34 C1881254 Inverted Squamous Cell Papilloma DisGeNET BeFree 3.390E-3 2.644E-2
1.648E-1
9.695E-1
 1 11
35 C3714636 Pneumonitis DisGeNET BeFree 3.489E-3 2.644E-2
1.648E-1
9.979E-1
 2 309
36 C0850666 helicobacter pylori infection DisGeNET BeFree 3.556E-3 2.644E-2
1.648E-1
1.000E0
 2 312
37 C0400966 Non-alcoholic Fatty Liver Disease DisGeNET Curated 3.669E-3 2.644E-2
1.648E-1
1.000E0
 2 317
38 C1540912 Hypereosinophilic syndrome DisGeNET Curated 3.698E-3 2.644E-2
1.648E-1
1.000E0
 1 12
39 C0399352 Developmental absence of tooth DisGeNET Curated 3.698E-3 2.644E-2
1.648E-1
1.000E0
 1 12
40 C0263662 Disseminated eosinophilic collagen disease DisGeNET BeFree 3.698E-3 2.644E-2
1.648E-1
1.000E0
 1 12
41 C1402291 Pigmented lesions DisGeNET BeFree 4.005E-3 2.697E-2
1.681E-1
1.000E0
 1 13
42 C0268136 Xeroderma pigmentosum, group B DisGeNET Curated 4.005E-3 2.697E-2
1.681E-1
1.000E0
 1 13
43 C0268060 Juvenile hemochromatosis DisGeNET Curated 4.313E-3 2.697E-2
1.681E-1
1.000E0
 1 14
44 C0206721 Inverted Papilloma DisGeNET BeFree 4.313E-3 2.697E-2
1.681E-1
1.000E0
 1 14
45 C1737329 Dysmorphism DisGeNET BeFree 4.313E-3 2.697E-2
1.681E-1
1.000E0
 1 14
46 C0024115 Lung diseases DisGeNET Curated 4.430E-3 2.697E-2
1.681E-1
1.000E0
 2 349
47 C0023492 Leukemia, T-Cell DisGeNET Curated 4.581E-3 2.697E-2
1.681E-1
1.000E0
 2 355
48 C0850639 premalignant lesion DisGeNET BeFree 4.620E-3 2.697E-2
1.681E-1
1.000E0
 1 15
49 C0151798 Hepatic necrosis DisGeNET Curated 4.620E-3 2.697E-2
1.681E-1
1.000E0
 1 15
50 C0034069 Pulmonary Fibrosis DisGeNET Curated 5.099E-3 2.830E-2
1.765E-1
1.000E0
 2 375
Show 45 more annotations